Trial Profile
Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2015
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Jul 2014 New trial record